Track market-moving stories before they get noisy

Key Takeaways Annaly expects Q3 earnings to cover its 75-cent dividend despite an 11.4% sequential decline in book value.NLY sees mid-to-high-teen Agency mortgage returns and 13-16% residential credit investment returns.Annaly maintains a 100% hedge ratio and $8.5 billion in assets available for financing amid market volatility.
Annaly Capital Management, Inc. (NLY - Free Report) emphasized dividend sustainability, disciplined leverage and selective investment opportunities during its third-quarter 2026 earnings call, despite significant pressure on mortgage-backed securities and book value.

Management maintained a constructive outlook across its three investment businesses while acknowledging persistent interest-rate volatility, higher funding costs and housing affordability challenges.

NLY Defends Dividend Amid Book Value PressureChief executive officer and Co-Chief investment officer David Finkelstein emphasized that Annaly's existing portfolio continues to support its quarterly dividend of 75 cents per share.

Responding to a Keefe, Bruyette & Woods analyst, Finkelstein said management expects earnings available for distribution (EAD) to exceed the dividend again in the fourth quarter.

EAD reached 80 cents per share, exceeding the Zacks Consensus Estimate of 77 cents per share. However, reported revenues of $543.6 million missed the $596.1-million consensus. Book value declined 11.4% sequentially to $17.86.

Annaly Maintains Defensive Hedging Amid VolatilityFinkelstein attributed the difficult quarter to rising Treasury yields, wider mortgage spreads and elevated interest-rate volatility. These conditions contributed to a negative 7.6% economic return.

Chief financial officer Serena Wolfe highlighted that economic leverage increased to 5.9 times from 5.6 times, primarily reflecting lower equity. The hedge ratio increased to 100% from 97%.

During discussions with Piper Sandler, Finkelstein explained that management had increased Treasury futures hedges during the market sell-off and intends to consider replacing some futures with interest-rate swaps.

NLY Sees Higher Returns in Agency MortgagesHead of Agency V.S. Srinivasan explained that wider mortgage spreads have improved prospective investment returns, particularly for 5.5% and 6% coupon securities.

Management identified prospective Agency returns in the mid-to-high teens, supported by attractive entry spreads and continued demand from institutional investors.

Finkelstein noted that Annaly rotated more than $2 billion of seasoned mortgage pools into higher-coupon securities early in the fourth quarter. Management expects declining volatility to improve market conditions while continuing to monitor duration exposure.

Annaly Prioritizes Residential Credit ExpansionCo-Chief investment officer and Head of residential credit Michael Fania highlighted record quarterly correspondent loan fundings of $5.8 billion and $7.4 billion in third-quarter securitizations.

During the Piper Sandler discussion, Finkelstein identified residential credit as management's preferred destination for incremental capital, followed closely by Agency mortgages and then mortgage servicing rights.

Fania outlined prospective residential credit returns of 13% to 16%, supported by securitization opportunities and financing arrangements. He also emphasized conservative underwriting as housing affordability pressures persist.

NLY Expects Mortgage Servicing OpportunitiesHead of mortgage servicing rights Ken Adler highlighted the portfolio's expansion to $4.3 billion, supported by selective bulk purchases and growing flow-channel activity.

Adler explained that higher interest rates support servicing cash flows through reduced mortgage prepayments and increased income earned on borrower escrow balances.

Responding to a JPMorgan analyst, Adler said industry consolidation, technological efficiency and weak origination profitability should encourage continued servicing-rights sales. Finkelstein added that Annaly remains selective about acquisition pricing.

Annaly Balances Liquidity With Capital DeploymentWolfe reported $8.5 billion of assets available for financing, supporting the company's flexibility amid uncertain market conditions.

Management raised $757 million through common equity issuance and redeemed approximately $443 million of preferred stock, actions Finkelstein connected to capital structure optimization.

Finkelstein maintained that current leverage provides sufficient earnings potential, although the company retains capacity for tactical expansion. His remarks emphasized balancing investment opportunities against capital preservation rather than aggressively increasing exposure.

NLY Maintains a Selective OutlookManagement entered the fourth quarter expecting some moderation in volatility while remaining vigilant about interest-rate exposure and mortgage market conditions.

Finkelstein's overarching message centered on diversified earnings, available liquidity and disciplined capital allocation across Agency mortgages, residential credit and servicing rights.

What NLY's Zacks Rank and Style Scores IndicateAnnaly currently carries a Zacks Rank #2 (Buy), indicating favorable near-term earnings estimate revision characteristics. Its Value Score of B and Momentum Score of A highlight relatively attractive valuation and price momentum characteristics. 

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

However, the Growth Score of F indicates weak growth characteristics, while the VGM Score of C reflects a mixed overall profile across value, growth and momentum. The favorable Value and Momentum Scores complement its Zacks Rank, but the weaker Growth and composite scores warrant consideration. The Zacks Rank remains subject to change as analysts revise earnings estimates following the latest results.

In its upcoming report, Aon (AON - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $3.34 per share, reflecting an increase of 9.5% compared to the same period last year. Revenues are forecasted to be $4.08 billion, representing a year-over-year increase of 2%.

The current level reflects a downward revision of 3.1% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.

Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.

While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.

With that in mind, let's delve into the average projections of some Aon metrics that are commonly tracked and projected by analysts on Wall Street.

The consensus estimate for 'Revenue- Health Solutions' stands at $976.74 million. The estimate suggests a change of +4.5% year over year.

The consensus among analysts is that 'Revenue- Wealth Solutions' will reach $453.13 million. The estimate points to a change of -16.1% from the year-ago quarter.

Analysts expect 'Revenue- Reinsurance Solutions' to come in at $557.33 million. The estimate points to a change of +3.8% from the year-ago quarter.

Analysts predict that the 'Revenue- Commercial Risk Solutions' will reach $2.09 billion. The estimate indicates a change of +4.9% from the prior-year quarter.

The collective assessment of analysts points to an estimated 'Commercial Risk Solutions - Organic Revenue Growth' of 5.4%. Compared to the present estimate, the company reported 7.0% in the same quarter last year.

It is projected by analysts that the 'Reinsurance Solutions - Organic Revenue Growth' will reach 4.4%. The estimate is in contrast to the year-ago figure of 8.0%.

Analysts' assessment points toward 'Wealth Solutions - Organic Revenue Growth' reaching 3.2%. Compared to the current estimate, the company reported 5.0% in the same quarter of the previous year.

The combined assessment of analysts suggests that 'Consolidated - Organic Revenue Growth' will likely reach 4.7%. The estimate is in contrast to the year-ago figure of 7.0%.

According to the collective judgment of analysts, 'Health Solutions - Organic Revenue Growth' should come in at 4.3%. Compared to the present estimate, the company reported 6.0% in the same quarter last year.

View all Key Company Metrics for Aon here>>>

Shares of Aon have demonstrated returns of +11.1% over the past month compared to the Zacks S&P 500 composite's -1.2% change. With a Zacks Rank #4 (Sell), AON is expected to lag the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Crown Castle Inc. (NYSE:CCI) shares are gaining Thursday on reports that SpaceX is negotiating tower leases with the company as it hunts for at least 80,000 U.S. cell sites.

Crown Castle shares are powering higher. Why is CCI stock surging? Crown Castle Stock Rises On SpaceX Lease TalksSpaceX Exploration Technologies Corp. (NASDAQ:SPCX) is working to secure 80,000 or more cell sites nationwide, and Crown Castle sits among the tower companies at the table, people familiar with the matter told Bloomberg.

In late trading, Crown Castle stock rose double digits after the news broke. Wireless carriers AT&T, Verizon and T-Mobile moved the other way, each down roughly 5% on competition worries.

CEO Chris Hillabrant did not confirm any agreement during Wednesday’s earnings call. Pressed on whether SpaceX, Amazon.com Inc or other satellite providers are negotiating leases, Hillabrant replied, “You can assume that we’re talking to all parties.” He would not name specific customers.

Why SpaceX Talks Help Crown CastleCrown Castle is one of the largest owners of cellular towers. Wireless carriers typically lease space on those towers instead of owning the sites. SpaceX needs towers to connect reliably with users on the ground, so it could become a major new tenant. Deals of that scale may be worth billions of dollars.

Tower stocks also reacted to SpaceX news earlier this month. They rose when SpaceX bought low-band spectrum, which suggests the market expects new business as SpaceX builds out its network.

SpaceX Pushes Toward a Fourth Wireless CarrierSpaceX CEO Elon Musk has set his sights on a standalone wireless carrier built from nothing. Two recent moves back that plan: low-band spectrum SpaceX bought, and Federal Communications Commission approval to launch 15,000 satellites that serve phones directly.

Hillabrant said the spectrum deal marks a big step toward broad mobile coverage.

CCI Shares Are SoaringCCI Price Action: Crown Castle shares were up 9.44% at $86.27 at the time of publication on Friday, according to Benzinga Pro.

Read Next

Image: JHVE Photo/Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

Key Takeaways Pentair is expected to report Q3'26 earnings of $1.07 per share, down 13.7% y/y.Water Solutions and Flow are expected to offset Pool weakness, with Flow sales projected to grow 8.9%.Pentair's Pool sales are projected to fall 25% as destocking, weak demand and inflation weigh on volumes.
Pentair plc. (PNR - Free Report) is set to release third-quarter 2026 results on Oct. 27, before the opening bell.

The Zacks Consensus Estimate for PNR’s third-quarter sales is pegged at $963.6 million, indicating a 5.7% decline from the year-ago reported figure.

The consensus estimate for PNR’s earnings has been unchanged at $1.07 over the past 60 days. The estimate suggests a year-over-year decline of 13.7%.

Image Source: Zacks Investment Research

Pentair’s Strong Earnings Surprise HistoryPNR’s earnings beat the Zacks Consensus Estimate in the trailing four quarters, delivering an average surprise of 3%. This is depicted in the following chart.

Image Source: Zacks Investment Research

What the Zacks Model Unveils for PNR StockOur model does not conclusively predict an earnings beat for Pentair this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. However, that is not the case here, as you can see below.

Earnings ESP: Pentair has an Earnings ESP of -1.56%. You can uncover the best stocks before they are reported with our Earnings ESP Filter.

Zacks Rank: PNR currently carries a Zacks Rank #3.

Factors Likely to Have Shaped Pentair’s Q3 PerformanceFor the third quarter of 2026, PNR expects reported sales to fall 4-6% year over year. Over the past few quarters, Pentair’s revenues have been driven by the Water Solutions and Flow segments, which have helped offset the decline in the Pool segment. This is expected to have continued in the third quarter of 2026 as well.

The Water Solutions segment has been witnessing a decrease in sales in the past few quarters, reflecting the impacts of portfolio exits. However, return on sales improved 560 basis points to 30% in the second quarter of 2026, supported by productivity and price exceeding inflation.

Pentair expects Water Solutions sales to be flat in 2026, with low-single-digit sales growth expected in the third quarter of 2026. Our model predicts the Water Solutions segment’s net sales to rise 1.4% year over year to $422 million. Volumes are expected to dip 2.7%, while pricing is anticipated to rise 3.1% in the quarter.

For the third quarter of 2026, the company expects Flow sales to rise in the high single digit. We expect the Flow segment’s sales to be $274 million, indicating an increase of 8.9% from the prior-year quarter’s actual. Our model predicts a 1.2% year-over-year jump in volumes. Pricing is expected to have a positive impact of 2.7%, while acquisitions, reflecting the contribution of Hydra-stop, are expected to have added 4%.

Pentair’s volume outlook deteriorated materially in the second quarter of 2026 as Pool channel partners reduced orders to right-size inventory. Pool sales fell 42% year over year, including about $170 million of destocking. Weak end-market demand amid elevated interest rates and persistent inflation continues to impact demand. Third-quarter 2026 Pool sales are expected to decline 23-25%, extending the revenue drag into the second half.

We anticipate a year-over-year volume decline of 29%, while pricing is expected to rise 3.4% in the third quarter. Our model projects the Pool segment’s sales for the third quarter of 2026 to fall 25% from the year-ago actual to $266 million.

PNR Stock Price PerformancePentair shares have lost 49.9% over the past year compared with the industry’s 2.5% decline.

Image Source: Zacks Investment Research

Stocks That Warrant a LookHere are some companies with the right combination of elements to post an earnings beat in their upcoming releases.

Eaton Corporation plc (ETN - Free Report) , slated to release third-quarter 2026 results soon, has an Earnings ESP of +0.53% and a Zacks Rank of 2 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.

The Zacks Consensus Estimate for Eaton’s third-quarter 2026 earnings is pegged at $3.53 per share, suggesting a year-over-year rise of 15%. ETN has a trailing four-quarter average surprise of 1.3%.

Deere & Company (DE - Free Report) , slated to release fourth-quarter fiscal 2026 results on Nov. 25, has an Earnings ESP of +3.59% and a Zacks Rank of 3 at present.

The Zacks Consensus Estimate for Deere’s fourth-quarter fiscal 2026 earnings is pegged at $4.07 per share, indicating a year-over-year rise of 3.6%. DE has a trailing four-quarter average surprise of 11.1%.

Emerson Electric Co. (EMR - Free Report) , slated to release fourth-quarter fiscal 2026 results on Nov. 4, has an Earnings ESP of +1.00% and a Zacks Rank of 2 at present.

The Zacks Consensus Estimate for Emerson Electric’s fourth-quarter 2026 earnings is pegged at $1.84 per share, implying a year-over-year rise of 13%. EMR has a trailing four-quarter average surprise of 1.3%.

Adams Diversified Equity Fund Inc. grew its position in CSX Corporation (NASDAQ:CSX – Free Report) by 8.2% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 516,000 shares of the transportation company’s stock after acquiring an additional 39,000 shares during the period. Adams Diversified Equity Fund Inc.’s holdings in CSX were worth $23,999,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of CSX. Archer Investment Corp acquired a new position in CSX in the second quarter worth $26,000. N.E.W. Advisory Services LLC bought a new stake in shares of CSX during the second quarter worth $27,000. Pin Oak Investment Advisors Inc. acquired a new stake in shares of CSX in the second quarter valued at $29,000. Manning & Napier Advisors LLC acquired a new stake in shares of CSX in the second quarter valued at $30,000. Finally, Arlington Trust Co LLC increased its stake in shares of CSX by 58.0% in the second quarter. Arlington Trust Co LLC now owns 681 shares of the transportation company’s stock valued at $32,000 after buying an additional 250 shares in the last quarter. 73.57% of the stock is owned by institutional investors and hedge funds.

More CSX News Here are the key news stories impacting CSX this week:

Positive Sentiment: Q3 earnings and revenue beat expectations. CSX reported $0.57 in adjusted EPS versus the $0.53 consensus estimate and $4.02 billion in revenue versus expectations of $3.96 billion. Revenue increased 12% year over year, while net earnings reached $1.05 billion. CSX increases earnings and revenue Positive Sentiment: Volumes and margins improved materially. Total volume rose 5%, with intermodal volume up 7% to a record level. Operating income increased 44% to $1.57 billion, and the operating margin expanded to 39.1%. Management also cited a 3% reduction in nonfuel costs, supporting the view that the improvement was not solely driven by fuel surcharges. CSX: 3 Key Takeaways for Long-Term Investors Positive Sentiment: Management offered constructive growth targets. CSX projects high-single-digit revenue growth in 2026 and is targeting more than 350 basis points of operating-margin expansion. Higher rail volumes may also benefit CSX relative to trucking companies as elevated fuel costs pressure truck transportation. CSX projects 2026 revenue growth Positive Sentiment: Analysts raised their estimates. Bank of America increased its price target to $57 from $55 with a Buy rating, while JPMorgan raised its target to $58 and maintained an Overweight rating. CSX Analysts Boost Their Forecasts Neutral Sentiment: CSX announced the elimination of more than 100 management positions, which could improve efficiency but may also signal ongoing cost-control efforts. CSX eliminates management positions Negative Sentiment: Risks include valuation concerns and conflicting analyst views: Morgan Stanley maintained a $32 Sell target, while Raymond James reduced its target to $53. A law firm is also investigating potential class-action claims related to a reported customer-data breach. CSX Sell Rating Maintained Wall Street Analysts Forecast Growth A number of research analysts recently issued reports on the company. Morgan Stanley set a $32.00 price target on shares of CSX and gave the stock an “underweight” rating in a research report on Monday, July 6th. JPMorgan Chase & Co. increased their price objective on shares of CSX from $57.00 to $58.00 and gave the stock an “overweight” rating in a report on Thursday. Bank of America raised their price objective on shares of CSX from $55.00 to $57.00 and gave the company a “buy” rating in a research report on Thursday. Argus set a $56.00 target price on shares of CSX in a research note on Friday, July 31st. Finally, Robert W. Baird boosted their target price on shares of CSX from $49.00 to $53.00 and gave the stock an “outperform” rating in a research note on Tuesday, July 7th. Eighteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $51.83. Read Our Latest Research Report on CSX

CSX Price Performance Shares of CSX stock opened at $51.67 on Friday. The stock has a 50-day moving average price of $48.69 and a 200 day moving average price of $47.59. The company has a quick ratio of 0.72, a current ratio of 0.82 and a debt-to-equity ratio of 1.22. The firm has a market cap of $95.72 billion, a price-to-earnings ratio of 25.08, a PEG ratio of 2.28 and a beta of 1.21. CSX Corporation has a 12 month low of $33.63 and a 12 month high of $53.60.

CSX (NASDAQ:CSX – Get Free Report) last announced its quarterly earnings data on Wednesday, October 21st. The transportation company reported $0.57 earnings per share for the quarter, topping the consensus estimate of $0.53 by $0.04. CSX had a return on equity of 26.31% and a net margin of 23.97%. The firm had revenue of $4.02 billion during the quarter, compared to analysts’ expectations of $3.96 billion. During the same period in the previous year, the business posted $0.44 EPS. The company’s quarterly revenue was up 12.0% compared to the same quarter last year. Research analysts expect that CSX Corporation will post 1.99 EPS for the current year.

CSX Announces Dividend The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Monday, November 30th will be given a dividend of $0.14 per share. The ex-dividend date is Monday, November 30th. This represents a $0.56 annualized dividend and a dividend yield of 1.1%. CSX’s payout ratio is currently 32.37%.

CSX Profile (Free Report)

CSX Corporation is a transportation company whose primary business is freight railroading through its CSX Transportation subsidiary. The company operates an extensive rail network across the eastern United States, serving major industrial centers, population hubs, ports and distribution markets.

CSX transports a broad range of products, including chemicals, agricultural and food products, forest products, minerals, metals, automotive goods and other manufactured merchandise. Its services also include intermodal transportation, which combines rail service with trucks and containers, as well as the movement of coal and other bulk commodities.

The company traces its roots to the formation of CSX Corporation in 1980 through the merger of Chessie System and Seaboard Coast Line Industries.

Recommended Stories Five stocks we like better than CSX Is Texas Instruments Setting Up for Its Next Big Breakout? Pegasystems’ Q3 Miss Exposed the Problem Standing Between AI and Cash Flow Lam Research’s Earnings Beat Wasn’t the Real Story—Its 2027 Outlook Was Tesla’s Flying-Car Hype Hits an Earnings Reality Check Want to see what other hedge funds are holding CSX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CSX Corporation (NASDAQ:CSX – Free Report).

Receive News & Ratings for CSX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSX and related companies with MarketBeat.com's FREE daily email newsletter.

Compass Wealth Management LLC cut its stake in shares of Applied Materials, Inc. (NASDAQ:AMAT – Free Report) by 6.3% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 32,178 shares of the manufacturing equipment provider’s stock after selling 2,179 shares during the quarter. Applied Materials makes up 3.1% of Compass Wealth Management LLC’s portfolio, making the stock its 4th largest holding. Compass Wealth Management LLC’s holdings in Applied Materials were worth $16,455,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Curry Webb Wealth Management LLC acquired a new stake in shares of Applied Materials in the third quarter valued at $30,000. SeaCrest Wealth Management LLC raised its holdings in shares of Applied Materials by 1.1% in the third quarter. SeaCrest Wealth Management LLC now owns 6,895 shares of the manufacturing equipment provider’s stock valued at $3,526,000 after buying an additional 78 shares during the last quarter. NBT Bank N.A. acquired a new position in Applied Materials during the 3rd quarter worth about $1,542,000. Isthmus Partners LLC lifted its position in Applied Materials by 1.9% during the 3rd quarter. Isthmus Partners LLC now owns 34,665 shares of the manufacturing equipment provider’s stock worth $17,727,000 after buying an additional 649 shares in the last quarter. Finally, Root Financial Partners LLC lifted its position in Applied Materials by 3.1% during the 3rd quarter. Root Financial Partners LLC now owns 2,351 shares of the manufacturing equipment provider’s stock worth $1,202,000 after buying an additional 71 shares in the last quarter. 80.56% of the stock is owned by institutional investors.

Insider Buying and Selling In other Applied Materials news, CFO Brice Hill sold 7,500 shares of the stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $479.25, for a total value of $3,594,375.00. Following the transaction, the chief financial officer owned 128,613 shares of the company’s stock, valued at approximately $61,637,780.25. This represents a 5.51% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Judy Bruner sold 1,000 shares of the business’s stock in a transaction dated Tuesday, September 8th. The stock was sold at an average price of $465.00, for a total value of $465,000.00. Following the transaction, the director owned 25,544 shares of the company’s stock, valued at $11,877,960. The trade was a 3.77% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 9,225 shares of company stock valued at $4,454,181 over the last ninety days. Insiders own 0.30% of the company’s stock.

Applied Materials Price Performance Applied Materials stock opened at $375.58 on Friday. The business’s 50-day simple moving average is $469.97 and its 200 day simple moving average is $487.71. The stock has a market cap of $298.06 billion, a price-to-earnings ratio of 32.38, a P/E/G ratio of 1.14 and a beta of 1.60. Applied Materials, Inc. has a 12-month low of $203.40 and a 12-month high of $739.67. The company has a quick ratio of 1.79, a current ratio of 2.42 and a debt-to-equity ratio of 0.20. Applied Materials (NASDAQ:AMAT – Get Free Report) last announced its quarterly earnings data on Thursday, August 13th. The manufacturing equipment provider reported $3.50 earnings per share for the quarter, topping the consensus estimate of $3.40 by $0.10. Applied Materials had a return on equity of 38.02% and a net margin of 30.05%. The firm had revenue of $9.12 billion during the quarter, compared to analysts’ expectations of $8.99 billion. During the same period in the previous year, the business posted $2.48 EPS. The company’s quarterly revenue was up 24.8% compared to the same quarter last year. Applied Materials has set its Q4 2026 guidance at 3.820-4.220 EPS. As a group, research analysts anticipate that Applied Materials, Inc. will post 12.79 earnings per share for the current year.

Applied Materials Announces Dividend The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 10th. Investors of record on Thursday, November 19th will be paid a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Thursday, November 19th. Applied Materials’s payout ratio is 18.28%.

Analysts Set New Price Targets AMAT has been the topic of a number of research analyst reports. Citigroup reissued a “buy” rating and set a $710.00 price objective (up from $550.00) on shares of Applied Materials in a report on Monday, August 3rd. Needham & Company LLC dropped their target price on shares of Applied Materials from $740.00 to $580.00 and set a “buy” rating for the company in a research note on Friday, October 16th. New Street Research reduced their target price on shares of Applied Materials from $580.00 to $525.00 and set a “neutral” rating on the stock in a research report on Friday, August 14th. KeyCorp increased their price target on shares of Applied Materials from $550.00 to $750.00 and gave the company an “overweight” rating in a research note on Monday, June 29th. Finally, B. Riley Financial reissued a “buy” rating and set a $700.00 price target (down from $790.00) on shares of Applied Materials in a research note on Friday, August 14th. Thirty analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat.com, Applied Materials presently has an average rating of “Moderate Buy” and an average price target of $632.70.

Check Out Our Latest Stock Analysis on Applied Materials

Key Applied Materials News Here are the key news stories impacting Applied Materials this week:

Positive Sentiment: Applied Materials saw approximately $102.1 million of net ETF buying on Tuesday, indicating continued institutional demand for the stock despite recent weakness. Applied Materials Sees $102.1 Million in Net ETF Buying on Tuesday Positive Sentiment: The company’s Semiconductor Systems business is positioned to benefit from AI-chip investment in advanced logic, DRAM and advanced packaging. These trends could support revenue growth and margin expansion in coming years. Can Semiconductor Systems Drive AMAT’s Next Growth Phase? Neutral Sentiment: Applied Materials will report fourth-quarter and fiscal 2026 results on November 12, 2026. The announcement gives investors a clear upcoming catalyst, but contains no change to earnings guidance. Applied Materials to Report Fourth Quarter and Fiscal 2026 Results on Nov. 12, 2026 Negative Sentiment: Lam Research’s outlook, described as only “a bit higher,” disappointed investors following an otherwise strong quarter. Its warning that supply constraints could limit growth pressured the broader chip-equipment group, including AMAT. Applied Materials Sinks on Lam’s Outlook Negative Sentiment: The sector-wide selloff reflects concerns that equipment makers may face near-term capacity and supply limitations even as AI demand remains strong. Applied Materials’ shares also remain below their recent moving averages, amplifying investor caution. Lam Research Sinks as Supply Constraints Cap Outlook Negative Sentiment: Investors have reacted cautiously to Applied Materials’ 2030 plan, including a target of more than $12 billion in services revenue and roughly 54% non-GAAP gross margin. The long-term targets may require substantial execution and are not immediately easing concerns about the current equipment cycle. Applied Materials Slides After Targeting $12 Billion in Services by 2030 Applied Materials Profile (Free Report)

Applied Materials, Inc is a technology company that supplies equipment, services and software used to manufacture semiconductors and advanced displays. Its products help customers fabricate the integrated circuits and other components used in computers, mobile devices, data centers, automobiles and a range of connected technologies.

The company’s offerings include systems for materials engineering, wafer fabrication, inspection and process control, along with equipment and services designed to improve manufacturing productivity and yield.

Featured Articles Five stocks we like better than Applied Materials Is Texas Instruments Setting Up for Its Next Big Breakout? Pegasystems’ Q3 Miss Exposed the Problem Standing Between AI and Cash Flow Lam Research’s Earnings Beat Wasn’t the Real Story—Its 2027 Outlook Was Tesla’s Flying-Car Hype Hits an Earnings Reality Check Want to see what other hedge funds are holding AMAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Applied Materials, Inc. (NASDAQ:AMAT – Free Report).

Receive News & Ratings for Applied Materials Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied Materials and related companies with MarketBeat.com's FREE daily email newsletter.

The market expects Cenovus Energy (CVE - Free Report) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.

The earnings report might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus EstimateThis oil company is expected to post quarterly earnings of $1.21 per share in its upcoming report, which represents a year-over-year change of +132.7%.

Revenues are expected to be $11.71 billion, up 22.2% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 4.23% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Cenovus?For Cenovus, the Most Accurate Estimate is the same as the Zacks Consensus Estimate, suggesting that there are no recent analyst views which differ from what have been considered to derive the consensus estimate. This has resulted in an Earnings ESP of 0%.

On the other hand, the stock currently carries a Zacks Rank of #1.

So, this combination makes it difficult to conclusively predict that Cenovus will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Cenovus would post earnings of $1.11 per share when it actually produced earnings of $1.11, delivering no surprise.

Over the last four quarters, the company has beaten consensus EPS estimates three times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Cenovus doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

Groupon (GRPN - Free Report) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

Shares of this online daily deal service have returned -22.3% over the past month versus the Zacks S&P 500 composite's -1.2% change. The Zacks Internet - Commerce industry, to which Groupon belongs, has lost 3.1% over this period. Now the key question is: Where could the stock be headed in the near term?

While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.

Revisions to Earnings EstimatesRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.

Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.

For the current quarter, Groupon is expected to post a loss of $0.01 per share, indicating a change of +99.7% from the year-ago quarter. The Zacks Consensus Estimate remained unchanged over the last 30 days.

The consensus earnings estimate of -$0.14 for the current fiscal year indicates a year-over-year change of +93.2%. This estimate has remained unchanged over the last 30 days.

For the next fiscal year, the consensus earnings estimate of $0.95 indicates a change of +776.2% from what Groupon is expected to report a year ago. Over the past month, the estimate has remained unchanged.

Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Groupon is rated Zacks Rank #2 (Buy).

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Revenue Growth ForecastEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.

For Groupon, the consensus sales estimate for the current quarter of $129.41 million indicates a year-over-year change of +5.4%. For the current and next fiscal years, $517.75 million and $565.05 million estimates indicate +3.9% and +9.1% changes, respectively.

Last Reported Results and Surprise HistoryGroupon reported revenues of $124.68 million in the last reported quarter, representing a year-over-year change of -0.8%. EPS of -$0.04 for the same period compares with $0.46 a year ago.

Compared to the Zacks Consensus Estimate of $127.42 million, the reported revenues represent a surprise of -2.15%. The EPS surprise was +50%.

Over the last four quarters, the company surpassed EPS estimates just once. The company topped consensus revenue estimates just once over this period.

ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.

While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.

The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Groupon is graded C on this front, indicating that it is trading at par with its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Groupon. However, its Zacks Rank #2 does suggest that it may outperform the broader market in the near term.

Wall Street expects a year-over-year increase in earnings on higher revenues when WisdomTree, Inc. (WT - Free Report) reports results for the quarter ended September 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.

The earnings report, which is expected to be released on October 30, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.

While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.

Zacks Consensus EstimateThis company is expected to post quarterly earnings of $0.30 per share in its upcoming report, which represents a year-over-year change of +30.4%.

Revenues are expected to be $181.31 million, up 44.3% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.77% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for WisdomTree, Inc.?For WisdomTree, Inc., the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +0.88%.

On the other hand, the stock currently carries a Zacks Rank of #3.

So, this combination indicates that WisdomTree, Inc. will most likely beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that WisdomTree, Inc. would post earnings of $0.26 per share when it actually produced earnings of $0.31, delivering a surprise of +19.23%.

Over the last four quarters, the company has beaten consensus EPS estimates four times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

WisdomTree, Inc. appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

An Industry Player's Expected ResultsAmong the stocks in the Zacks Financial - Miscellaneous Services industry, Coinbase Global, Inc. (COIN - Free Report) , is soon expected to post loss of $0.18 per share for the quarter ended September 2026. This estimate indicates a year-over-year change of -112.5%. This quarter's revenue is expected to be $1.16 billion, down 38.1% from the year-ago quarter.

The consensus EPS estimate for Coinbase Global has been revised 72.2% lower over the last 30 days to the current level. However, a higher Most Accurate Estimate has resulted in an Earnings ESP of +171.22%.

When combined with a Zacks Rank of #3 (Hold), this Earnings ESP indicates that Coinbase Global will most likely beat the consensus EPS estimate. Over the last four quarters, the company surpassed EPS estimates just once.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

A Solana-based KIMCHI memecoin has plunged more than 95% after a promotional post linked to crypto trader Kimchi’s X account disappeared, triggering allegations of suspicious trading and questions about Pump.fun co-founder Alon’s involvement in promoting the token.

Summary

A KIMCHI token promoted through a QR code linked to trader Kimchi’s X account crashed after the post disappeared.
Lookonchain reported that the token briefly reached a $14 million market capitalization before falling more than 95%.
Blockchain analysts flagged profitable early trading, while allegations of hacking and deliberate fraud remain unconfirmed.
Pump.fun’s daily revenue and active addresses declined during the same period, without evidence establishing a direct connection.

According to blockchain analytics firm Lookonchain, Kimchi’s account promoted a newly launched token after reportedly receiving 500 million KIMCHI tokens, while Alon reposted the announcement. Both posts subsequently disappeared, and the token’s market capitalization collapsed after briefly reaching approximately $14 million.

The controversy began when an AI-generated promotional image appeared on Kimchi’s X account, featuring a QR code directing users to a newly created token on Pump.fun. Traders quickly bought the token, while Alon’s repost drew further attention to the promotion.

Within minutes, KIMCHI reportedly climbed past a $10 million market capitalization before reaching roughly $14 million. Its subsequent decline exceeded 95%, with some market observations placing the drop closer to 99% after the promotional post disappeared.

Kimchi token crashe, source: Lookonchain/X
Market capitalization measures the estimated value of a token’s supply at the prevailing price. The reported $14 million peak therefore does not establish that investors collectively lost $14 million or that an equivalent amount of money entered the market.

Crypto trader Arez questioned the sequence, alleging that the QR code’s destination changed after the token attracted substantial trading. The trader said Alon subsequently withdrew his repost, while some buyers were left holding tokens purchased near the peak.

The incident followed recent attention surrounding Kimchi’s relationship with Pump.fun.

Lookonchain identifies over $385K in suspected trading profits
Lookonchain’s investigation identified several wallets that reportedly accumulated KIMCHI at relatively low prices before selling during the rally. The analytics firm estimated that the transactions generated more than $385,000 in combined profits.

Investigators identified three Solana addresses for examining the associated transfers. The wallet activity described by Lookonchain raises questions about trading patterns, but blockchain transfers alone do not establish who controlled the addresses or whether the traders had advance knowledge of the promotion.

A separate Bitquery investigation documented activity involving another KIMCHI launch around October 20. Its researchers identified three linked wallets that bought a newly issued token and quickly sold their holdings, generating approximately $104,000 in gains.

Bitquery explicitly stated that it could not connect those wallets to the deployer through direct transfers. Its findings concern a separately identified token and transaction sequence, so the reported profits should not be combined with Lookonchain’s estimate without matching the contracts and timestamps.

Traders demand answers over deleted KIMCHI promotion
Following the collapse, some traders accused the accounts involved of promoting an unsafe token. An X user known as tontheneko demanded refunds, arguing that Alon should have verified the promotion before sharing it with his followers.

Hello @a1lon9, I hope you immediately refund anyone who lost money on this coin.

You literally retweeted a rug pull and made hundreds of people lose money.

It was your responsibility as @Pumpfun founder to double check and confirm what you are posting with kimchi before… pic.twitter.com/3QNtkWSYA8

— ton (@tontheneko) October 22, 2026

Those accusations remain allegations, not established findings of fraud or misconduct. Neither the promotional repost nor subsequent deletion independently proves that Alon or Kimchi coordinated the trading or benefited financially from the token’s price movements.

A suspected account hack has been suggested as another explanation, although the available statements do not confirm unauthorized access. No verified refund arrangement or official finding assigning responsibility was identified.

The episode follows scrutiny of Pump.fun token survival rates, with an October Bitquery study finding that 79% of launches in its sample recorded no trading after their first day. That study covered a larger token sample and did not examine the latest KIMCHI promotion specifically.

Pump.fun revenue falls as activity declines
Meanwhile, Lookonchain highlighted a decline in activity on Pump.fun after Kimchi reportedly removed the platform’s name from his X biography. The researcher compared daily revenue of $1.61 million with $1.35 million two days later, representing a decline of approximately 16%.

Active addresses fell from 178,539 to 159,492 over the same comparison, a drop of roughly 11%. However, the timing does not demonstrate that the KIMCHI controversy caused either decline.

The DefiLlama protocol dashboard separately showed approximately $1.35 million in daily revenue and 159,492 active addresses. Its methodology distinguishes platform revenue from total fees paid by traders.

Recently, Pump.fun introduced perpetual futures trading through Hyperliquid, expanding its services beyond memecoin launches. Subsequently, the platform launched Pump Bridge to support cross-chain transactions, with its published performance figures based on testing conducted between September 28 and October 7.

Disclosure: This article does not represent investment advice. The content and materials featured on this page are for educational purposes only.

Crypto asset management company Bitwise stated in its latest research that Solana stands out.

Accordingly, 72.8% of all SOL staked on the Solana network is concentrated among validators located in Europe.

Europe Leads in Solana Stake Distribution!
According to Bitwise’s Staking Report, the majority of SOL staked on the Solana network is concentrated in Europe. Europe ranks first with a 72.8% share, followed by North America with 16.2%, Asia with 10.6%, and South America with 0.4%.

The concentration in Europe is particularly evident in the region between Amsterdam, Frankfurt, and London. This distribution presents a remarkable picture in terms of geographical centralization and connection delays in the Solana network infrastructure.

According to the Bitwise report, the reduction in slot times has exacerbated regional disparities. This is because Solana gradually reduced slot times from 400 milliseconds to 250 milliseconds between August and September 2026 in an effort to increase network processing speed and reduce finalization times.

According to Bitwise, this change has contributed to faster transaction finalization while also reducing the time validators have to receive blocks, verify them, and submit votes.

The concentration of staking in Solana within Europe raises questions about the impact of MiCA regulations on staking services. However, the mere presence of a validator in Europe does not automatically necessitate licensing. According to ESMA, companies offering staking and custody services must comply with the relevant MiCA regulations, but neither Bitwise nor the Solana Foundation have provided an assessment of the direct regulatory implications of this concentration in Europe.

*This is not investment advice.

Follow our Telegram and X account now for exclusive news, analytics and on-chain data!

THORSday Community Podcast #244 ft. CBarraford, KentonC137 & Patriotsounds | October 22, 2026 | Watch the full episode on YouTube

By Raynalytics

TL;DRv3.21 was about 13 hours from adoption. Chad expects to cut v3.21.1 next week once two more pull requests merge, and once the paused churn resumes, $XMR is ready to launch.In its second week, SwapKit Rev-Share spent $841.60 in credits on swaps that earned THORChain $3.72K in fees, a 4.4x return that held steady as spending doubled.Chad is turning block time into an adjustable mimir so THORChain can step down from 6 seconds to 2 seconds one second at a time, and step back up without a new binary.About 20% of nodes have started voting to end rewards to liquidity pools. Kenton wants a formal ADR, while Denny and Chad made the case for protocol-owned liquidity (POL) instead.Chad unveiled Visual Review, a tool that turns any code change into an explainer page, and the solvency checker halted a small IBC exploit on its own at a loss of about $800.1. Monero Is Two Pull Requests and a Churn AwayAt recording time, v3.21 was roughly 13 hours from adoption. Chad said two more pull requests need to merge before the team can cut v3.21.1, which he expects next week. The churn is currently paused for issues that v3.21 fixes, so the remaining sequence is: adopt v3.21 and v3.21.1, restart the churn, and launch Monero.

"Once that's out and the churn is churning, we're live." (Chad)A community member asked whether THORChain could be a reorg target, citing the Qubic selfish-mining incidents on Monero. Chad said it comes down to confirmation counting. He described a method JP created years ago: wait enough blocks that the block rewards in that window exceed the value coming into the protocol. More confirmations mean slower trades, but because THORChain has no decentralized competition for $XMR and competes mainly with centralized exchanges, speed matters less at launch. Chad leans toward a higher confirmation count to start, with the exact number still to be researched. For contrast, he recalled Erik Voorhees telling him that ShapeShift used a single confirmation on Bitcoin for its whole history without a reorg incident.

Shielded Zcash addresses are not coming soon. Chad used AI to generate a full implementation in about 12 hours, but it added roughly 20,000 to 30,000 lines of code, and the devs pushed back on the complexity. What tipped Chad was Maya Protocol's data: only about 15% of its Zcash volume uses shielded addresses. The Zcash community is also working on rotating transparent addresses, which Chad expects would need no changes on THORChain's side. He will be at Zcash Foundation's Zcon7 in Cancún next week.

Beyond Monero, BSC is now on Router v6 alongside Base and Avalanche, and churnless chain additions are targeted for the next release or the one after. Asked about Zano, Chad said it is still well back in the queue. He named Substrate-based chains, Bittensor's $TAO and Dash as the short list after Monero, which he called by far the hardest chain THORChain has integrated.

2. SwapKit Rev-Share Holds at 4.4x in Week TwoChad returned to Ray's SwapKit Revenue Share dashboard for a second weekly check-in. Under the 20% Rev-Share, SwapKit has accrued $7.03K in credits and spent $841.60 of it on quote discounts, leaving a $6.19K balance. Swaps carrying those discounts earned THORChain $3.72K in fees, a 4.4x return, slightly below the 4.6x of week one. The discounted swaps added up to $1.96M in volume across 778 swaps, an average of about $2,500 each.

Chad's summary was that the numbers held. Spending roughly doubled over twice the time, and the ratio barely moved, which the hosts called a great sign.

The open question is still scale. Chad expects SwapKit to raise its spending after v3.21, and the hosts noted that the release fixes an affiliate code bug that should let SwapKit add more partners. If the ratio stays around 4.4x to 4.5x, he said raising the share from 20% to 25% would create the flywheel discussed last week, where every dollar SwapKit spends returns more than a dollar to its bucket, until SwapKit's market saturates. Week one is covered in last week's recap.

3. Should THORChain End LP Rewards?Kenton raised a vote already in motion: roughly 20% of nodes, about 27, have started voting to cancel rewards going to liquidity pools. Because it would be a big change to THORChain's economics, he suggested someone write a formal ADR.

The backdrop: for months the incentive pendulum sent nearly all rewards to nodes, then 20% of system income began flowing to POL. Now the pendulum is swinging back, and rewards are reaching legacy LPs again. Kenton's concern is that LPs need $RUNE to outperform to break even, but that same outperformance erodes the value of their accumulating rewards through impermanent loss. He believes POL should replace LPs over time. He also steelmanned the other side: if $RUNE never outperforms enough, those rewards could help pay LPs back. Boone has proposed paying rewards out to LPs directly to shield them from impermanent loss, and wrote in chat that most LPs would not benefit from rewards at current prices because synth leverage is so severe.

Denny, speaking as an LP, backed POL over LP rewards. Ray's POL Income dashboard shows 1.23M $RUNE of system income collected for POL, about $791,500 at current prices. Kenton added that $RUNE tracks volume, volume needs liquidity, and THORChain has lost roughly 75% to 80% of its liquidity since THORFi. He would end the rewards if it were his call, while acknowledging that node operators are also struggling on low yields. Node income is tracked on Ray's THORChain Financials page.

"We are grinding our way out of this hole. It's happening." (Denny)Chad favored POL because it is not mercenary capital. If there were another hack, POL would likely be first in line to absorb losses, rather than the Treasury, which paid for most past incidents. He said he wished THORChain had launched with both streaming swaps and POL from day one. For background, see the recap covering POL's launch.

4. A Gradual Path to 2-Second BlocksChad is revisiting 2-second blocks. The original code was merged about a year and a half ago, then pulled back because a hard switch felt risky and difficult to undo. His new approach is to make block time a mimir rather than a code change, so THORChain can move one step at a time and roll back if needed without releasing a new binary.

"We can walk it down from 6 seconds, what it is now, to 5 seconds to 4 seconds to 3 seconds to 2 seconds." (Chad)His analysis of mainnet suggests 2 seconds is a safe target: about 99% of blocks already complete in under 2 seconds. Around 1.5 seconds might be possible with Cosmos SDK performance gains, but Chad would be cautious. The mimir will be hard-coded to a range of 1 to 10 seconds, and going below 1 second would mean forking or replacing CometBFT, the consensus layer underneath.

On paper, the benefits are clear: streaming swaps would execute three times faster, arbitrage bots would rebalance pools more often, and the Rujira app layer would gain from faster blocks. Chad wants to measure how much of that shows up in practice before pushing lower, and hopes to move ahead within the next month or two. The idea first resurfaced in last week's recap.

5. The Quote-Versus-Fill Test Gets CheaperThe test proposed last week, comparing swap providers' quotes with what users actually receive, is moving forward with Treasury support. Kenton said he and Ray are working out the procedure, and credited Ray for running the numbers. The original plan of $1,000, $10,000 and $100,000 swaps would have meant a few million dollars in volume and, once fees and spreads were included, a cost of a couple hundred thousand dollars. The revised plan uses only $1,000 swaps: around 400 to 500 of them, roughly $400,000 to $500,000 in volume, for a cost of a few thousand dollars. Kenton said THORChain already wins larger quotes, and the low end of the size curve is where it misses volume, so that is the range worth studying.

On marketing, Kenton listed THORChain on a no-KYC exchange directory and asked the community to leave a review. THORChain will appear on the directory's exchange list once it has an XML quote feed, which Liquify agreed to build. He also asked the Unstoppable Wallet devs about Tor (.onion) and I2P addresses for THORChain Swap and set up a THORChain page on Bitcointalk.

Kenton's focus remains AI search. thorchain.org sits in the top 500 of about 120,000 sites on an AI-visibility tracker, though still at a B grade, and new affiliates requesting API keys say they found THORChain through ChatGPT, Claude or Google search. He is also looking into ChatGPT's new advertising, which could open a paid channel crypto lacks on Google.

After a press outlet turned a post about a 140 $RUNE Zcash pool bug into a negative story, Kenton said issues will still be disclosed on Discord and GitLab, but the main X account does not need to spotlight every minor bug.

6. Visual Review Turns Code Changes Into ExplainersChad unveiled Visual Review, a skill he built that turns a code change into a web page explaining it visually. He showed it on his dynamic fee merge request. The page includes a five-minute explainer video with chapters, interactive graphs, and a narrated walkthrough of every changed line, with fuzzy search by file name, function or snippet of code. The goal is to let anyone, technical or not, understand a change before it merges.

"It's my attention and my focus that is the most valuable resource in this process." (Chad)The merge request he showed runs to about 27,000 lines, of which roughly 1,483 are logic changes; the rest are tests and documentation. Huginn will generate these pages automatically, with a button at the top of each pull request. Chad has open-sourced the skill on GitLab, and Kenton added a Visual Review link to the thorchain.org footer during the show.

The dynamic fee change itself replaces the current step search, which moves 1 bps at a time, with a bracket search. Instead of trying 1, 2, 3, 4 and 5 bps, the model jumps from 1 bps to 20 bps, then tests the midpoint and narrows in. Bigger jumps make the market's reaction clearer and reach the best fee in fewer epochs. The change also lets the team switch an affiliate such as Symbiosis off and on to reset its data. Chad hopes to merge it for v3.22.

7. The Solvency Checker Stops an IBC ExploitTHORChain had what Chad called a tiny mini hack this week. A bug in the IBC implementation let an attacker make THORChain believe it had received $ATOM it never received. The first fake deposit was about 16 $ATOM, roughly $20, sent with a bad memo that triggered a refund. The attacker kept doubling that amount across five transactions.

The solvency checker only acts once a shortfall reaches $500, a buffer that avoids halting the chain over small discrepancies. Once that line was crossed, it halted things within about 20 to 30 seconds, with no human involvement, after an attack lasting seven or eight minutes. Chad expects the roughly $800 shortfall to be refilled from the reserve, probably in the next release. In chat, a viewer offered to open a merge request setting the threshold at $42,069.

"It's a success story in my mind, even though it's only $800." (Chad)Chad also wants more math-based safety checks. AI recently helped solve how to account for synthetics in LUVI, a measure that separates pool earnings from price moves and should almost always rise, so it can now act as an invariant that flags broken pool accounting without knowing the cause. LUVI checks were added to regression testing last week, and Chad plans to add them to mainnet code eventually, though it is not a top priority.

A community member also asked why the reserve holds about 25M $RUNE. Chad was not sure and suspects it relates to accounting from the summer hack. Kenton thought a store migration in v3.21 might address it. Long term, Chad said, the reserve would have a cap, with anything above it paid out as system income.

8. Faster CI and Huginn's Growing RoleChad shared a summary of recent changes to THORChain's continuous integration (CI), the automated tests every code change must pass. The team now runs nearly three times as many CI jobs per day, has added more than 1,300 unit tests, and introduced fuzz testing, mutation testing and adversarial-quorum testing. Typical CI time fell from 97 minutes to 24 minutes, and even the worst cases now finish in under 50 minutes, down from waits as long as seven hours.

Asked whether a large language model could formally verify the THORChain stack using Lean, Chad said Lean is a language for mathematical proofs and he does not think it applies to code. Instead, Huginn reviews every change and continuously audits the codebase, tracking which files it has scanned. By Chad's count, Huginn has found more security issues in the past year than every human contributor combined, by orders of magnitude, and it currently reports only the two highest priority levels. A full audit by the security team also turned up a few dozen issues, which are being addressed.

The bottleneck is human review. A community developer recently opened six or seven merge requests; generating one can take five minutes, while reviewing it can cost several engineers 45 minutes each. Chad estimated THORChain could merge 10 to 20 times more code per release without that constraint, though he stressed humans still review everything. Huginn now runs on its own Treasury-funded accounts, which freed Chad's own AI usage for projects like Visual Review.

"If you write code without having AI involved in that process, you're probably doing it wrong." (Chad)What to Watchv3.21 adoption, the v3.21.1 cut expected next week, and the churn resuming ahead of the $XMR launch.Whether SwapKit scales its Rev-Share spending after v3.21, whether the return holds near 4.4x, and whether the share moves to 25%.Whether an ADR on ending LP rewards is written, and how many nodes join the vote.The 2-second block mimir, hoped for within the next month or two.The dynamic fee bracket search in v3.22, and Visual Review pages on every pull request.The quote-versus-fill test, once Kenton and Ray finalize the procedure.Kenton's quarterly report, which he hopes to work on this weekend.Chad at Zcon7, a possible technical Rujira session with Pragmatic Monkey or CodeHans, and Chad's planned appearance on Joel Valenzuela's show.Schedule changes: Zodl on Friday, October 23, and the Saturday show moving an hour later.More THORChain data, check out raynalytics.net

Follow Raynalytics for more Weekly Analytics and Podcast recaps.

The market expects AutoNation (AN - Free Report) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.

The earnings report, which is expected to be released on October 30, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus EstimateThis auto retailer is expected to post quarterly earnings of $5.30 per share in its upcoming report, which represents a year-over-year change of +5.8%.

Revenues are expected to be $7.06 billion, up 0.3% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 5.82% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for AutoNation?For AutoNation, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -3.62%.

On the other hand, the stock currently carries a Zacks Rank of #5.

So, this combination makes it difficult to conclusively predict that AutoNation will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that AutoNation would post earnings of $5.43 per share when it actually produced earnings of $5.56, delivering a surprise of +2.39%.

Over the last four quarters, the company has beaten consensus EPS estimates three times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

AutoNation doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Expected Results of an Industry PlayerAmong the stocks in the Zacks Automotive - Retail and Whole Sales industry, Penske Automotive (PAG - Free Report) , is soon expected to post earnings of $3.44 per share for the quarter ended September 2026. This estimate indicates a year-over-year change of +6.5%. This quarter's revenue is expected to be $8.04 billion, up 4.5% from the year-ago quarter.

Over the last 30 days, the consensus EPS estimate for Penske has been revised 5% down to the current level. Nevertheless, the company now has an Earnings ESP of -0.44%, reflecting a lower Most Accurate Estimate.

This Earnings ESP, combined with its Zacks Rank #4 (Sell), makes it difficult to conclusively predict that Penske will beat the consensus EPS estimate. Over the last four quarters, the company surpassed consensus EPS estimates two times.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

Table of contents

Last Updated: October 23, 2026

The most reliable way to track Shiba Inu (SHIB) burns is to combine three sources: Shibburn for daily totals, a blockchain explorer such as Etherscan to verify each burn transaction, and ShibWatch or the official shib.io site for the state of ShibTorch, Shibarium’s own burn mechanism. No single tracker is official, and they do not count burns the same way.

About 410.85 trillion SHIB, or 41.08% of the original 1 quadrillion supply, has been burned according to Shibburn, but almost all of it comes from a single transaction by Ethereum co-founder Vitalik Buterin in May 2021. Burns today are tiny: about 673 million SHIB in the past 30 days, worth roughly $3,810. ShibTorch, the official burn portal, is under maintenance and has not burned SHIB since August 2025, according to ShibWatch.

Key Takeaways

Total burned: about 410.85 trillion SHIB according to Shibburn, of which about 410.44 trillion sits in a single dead address that holds Vitalik Buterin’s 2021 burn.
Recent burns: about 2.47 million SHIB in the past 24 hours (about $12), 67.2 million in seven days and 673.4 million in 30 days, according to Shibburn on October 23, 2026.
ShibTorch is paused: the Shibarium burn portal is under maintenance because the SHIB route on the Shibarium bridge has stayed closed since a September 2025 exploit.
Trackers disagree: Shibburn counts about 340 billion more burned SHIB than the three main burn addresses hold on-chain, and supply figures differ by several trillion SHIB between Shibburn and CoinMarketCap.
Headline burn rates mislead: recent spikes of 492% and 2,349% involved burns worth about $13 and $5.

SHIB Burn Data Today
MetricValueTotal SHIB burned (Shibburn)410,845,024,873,680 SHIB (41.08% of 1 quadrillion)Burned in the past 24 hours2,472,769 SHIB (about $12)Burned in the past 7 days67,240,450 SHIB (about $341)Burned in the past 30 days673,379,117 SHIB (about $3,810)Largest burn address balance410,437,114,516,937 SHIB (0xdEAD…2069)SHIB priceAbout $0.0000050ShibTorch statusUnder maintenance; last burn in August 2025 (ShibWatch)
Sources: Shibburn and Etherscan, October 23, 2026; price from CoinMarketCap; ShibTorch status from ShibWatch and U.Today, October 22, 2026. Shibburn’s 24-hour figure is a rolling window, so it changes through the day.

For live price levels, see our Shiba Inu price page.

Where to Check SHIB Burns: Trackers Compared
SourceWho runs itWhat it showsBest forCaveatsShibburn (shibburn.com)Independent; now managed by BurnalyticsTotal burned, 24-hour, 7-day and 30-day burns, recent burn transactions and top burnersQuick daily totalsNot affiliated with the Shiba Inu team; counts several burn addresses; does not publish the cut-off time of its 24-hour windowEtherscanIndependent block explorerSHIB balance of each burn address and every individual transactionVerifying a specific burnShows raw transfers and balances, not daily totals; you need the correct SHIB contract and burn addressShibWatchCommunity tracker; operator not namedShibTorch burn totals, the BONE waiting to be burned and the status of each Shibarium bridge laneChecking whether ShibTorch is workingUnofficial; reads contracts directly but is not auditedshib.io (ShibTorch page)Shiba Inu teamShibTorch burn activity and contractsThe official view of Shibarium burnsIts burn page was failing to load data on October 22, 2026 because the indexer behind it no longer runsThe Shib DailyShiba Inu teamAnnouncements about ShibTorch, Shibarium and burn mechanismsOfficial changes and explanationsThe team’s own outlet, so confirm claims on-chainShibariumscanShibarium block explorerTransactions on ShibariumChecking Shibarium-side activityHad indexed only about 54% of Shibarium blocks as of October 1, 2026
The practical setup is simple: bookmark Shibburn for the daily number, check any large or unusual burn on Etherscan, and look at ShibWatch or shib.io when headlines talk about Shibarium or ShibTorch burns.

SHIB Burn Addresses
The SHIB token contract on Ethereum is 0x95aD61b0a150d79219dCF64E1E6Cc01f0B64C4cE. Burned SHIB sits in addresses that no one controls, so the tokens can never move again.

AddressWhat it isSHIB held on October 23, 20260xdEAD000000000000000042069420694206942069Dead address used for Vitalik Buterin’s May 2021 burn410,437,114,516,936.90x000000000000000000000000000000000000dEaDCommon dead address; Shibburn says the team used it for ShibaSwap listings49,460,833,155.30x0000000000000000000000000000000000000000Null address; sending SHIB here destroys it and lowers the on-chain total supplyAbout 17.67 billion destroyed
Balances from Etherscan. The null address holds no balance because burns to it reduce SHIB’s on-chain total supply, which now stands at 999,982,327,167,466 SHIB instead of 1 quadrillion.

Why SHIB Burn Trackers Show Different Numbers
The three addresses above add up to about 410.50 trillion SHIB. Shibburn reports about 410.85 trillion, roughly 340 billion more, and does not publish the full list of addresses it counts. Media outlets have attributed the gap to Shibburn summing several burn addresses, but the exact method is not public.

Supply figures differ for a similar reason. CoinMarketCap and CoinGecko put SHIB’s total supply at about 589.50 trillion, which equals the on-chain supply minus the two dead addresses above, and its circulating supply at about 589.24 trillion. Shibburn shows a total of about 589.15 trillion and a circulating supply of about 585.49 trillion, because it treats more tokens as burned and excludes more wallets from circulation. Neither side lists every wallet it excludes, so a difference of a few trillion SHIB between sites is normal and does not mean anyone is wrong about the burns themselves.

This comparison is our own analysis of Shibburn, CoinMarketCap, CoinGecko and Etherscan data from October 23, 2026.

Why SHIB Burn Rate Headlines Mislead
Burn rate headlines compare one day’s burns with the day before, so tiny amounts can produce huge percentages. On October 19, the burn rate jumped 2,349% on about 1.10 million SHIB, worth about $5. On October 21, it rose 492% on about 2.7 million SHIB, worth about $13. In early October, a 182,140% spike was followed the next day by a reading of zero burned SHIB.

The more useful measure is burns as a share of supply. About 673 million SHIB burned in 30 days is roughly 0.0001% of the circulating supply. At that pace, burning just 1% of the supply would take about 714 years, according to Cryptoticker. By comparison, about 87 trillion SHIB sat on exchanges on October 21, roughly 129,000 times the monthly burn. Our analysis of SHIB’s burn rate explains the math in more detail.

What Happened to ShibTorch?
ShibTorch went live on August 16, 2024 as Shibarium’s community burn portal. Shibarium charges transaction fees in BONE, and under the network’s design about 70% of base fees is set aside to buy and burn SHIB, with 30% going to the treasury. A hard fork on August 9, 2024 automated that burn, and ShibTorch V2, released in January 2025, moved the portal into shib.io and simplified the bridge route the burns use.

The process has stalled. According to community member Mazrael, cited by U.Today on October 22, 2026, ShibTorch now swaps BONE for SHIB on Shibarium and then bridges the SHIB to a dead address on Ethereum. That SHIB lane on the Shibarium bridge has been closed since the September 12, 2025 exploit, in which an attacker used a flash loan of 4.6 million BONE and control of 10 of 12 validator signing keys to drain about $2.4 million. The BONE lane reopened on October 14, 2025 with a seven-day withdrawal delay, but the SHIB lane has not moved since October 2025, according to ShibWatch.

ShibTorch is now listed as under maintenance, with about 371 BONE waiting to be burned, below the threshold of 1,000 BONE that community members say triggers a burn. ShibWatch counts about 69.32 billion SHIB burned through Shibarium-related mechanisms in total, worth about $1.27 million at the time of the burns, and says ShibTorch has not burned since August 2025. Our report on what Shiba Inu is building covers the wider Shibarium roadmap.

A Short History of SHIB Burns
DateEventMay 16 to 17, 2021Vitalik Buterin burns about 410.24 trillion SHIB, about 41% of the supply and 90% of his remaining SHIB, worth up to $6.7 billion at the timeApril 2022A burn portal launches on ShibaSwap, rewarding burners with tokens that earn a share of RYOSHI fees; more than 8 billion SHIB is burned in its first 24 hoursDecember 5, 2023First Shibarium-linked burn: 8.2 billion SHIB, worth about $76,000, from fees collected on the networkAugust 9, 2024Shibarium hard fork automates the burn of 70% of base feesAugust 16, 2024ShibTorch goes live as Shibarium’s community burn portalJanuary 30, 2025ShibTorch V2 moves into shib.io with a simpler bridge routeSeptember 12, 2025Shibarium bridge exploit drains about $2.4 million; the SHIB bridge lane stays closedJuly 2026About 2.96 billion SHIB burned in the week to July 30, the biggest weekly total of the yearOctober 2026ShibTorch under maintenance; 30-day burns near 673 million SHIB
How to Verify a SHIB Burn Yourself

Find the transaction hash. A reliable burn report links to the transaction or names the wallet that sent it.
Open it on Etherscan. Check that the token is SHIB, at contract address 0x95aD61b0a150d79219dCF64E1E6Cc01f0B64C4cE, and not a copycat token.
Check the destination. The tokens should go to one of the burn addresses above or be destroyed through a verifiable contract.
Match the amount and time. Compare the on-chain amount with the reported figure, and check whether a burn rate refers to 24 hours, seven days or another period.
Separate burns from pledges. Tokens that are pledged, locked or waiting in a contract, like the BONE sitting in ShibTorch, are not burned until the transaction happens.

Do SHIB Burns Affect the Price?
Not meaningfully at today’s pace. With about 589 trillion SHIB in circulation and burns of under a billion a month, supply is effectively fixed, so SHIB’s price depends on demand, Bitcoin’s direction and meme coin sentiment far more than on burns. Our analysis of whether Shiba Inu can reach 1 cent shows how many tokens would need to be burned for that to change, and our Shiba Inu price prediction covers the forecasts from 2026 to 2040. If you plan to buy SHIB, our guide on where to buy Shiba Inu compares exchanges and wallets.

Data sources: Shibburn and Burnalytics (burn totals), Etherscan (SHIB contract and burn address balances), ShibWatch (ShibTorch and bridge status), U.Today and CoinTurk (ShibTorch maintenance), The Shib Daily (ShibTorch launch, V2 and bridge reopening), The Block (bridge exploit), Decrypt and CoinDesk (Vitalik Buterin’s 2021 burn), Cryptoticker (burn rate math and exchange balances), CryptoPotato and U.Today (burn rate spikes) and CoinMarketCap and CoinGecko (supply and price), as of October 23, 2026.

This article is for informational purposes only and does not constitute financial advice. Cryptocurrency markets are volatile; always do your own research before investing.

Frequently Asked Questions
How much SHIB has been burned?
About 410.85 trillion SHIB, or 41.08% of the original 1 quadrillion supply, according to Shibburn on October 23, 2026. Almost all of it comes from Vitalik Buterin’s burn of about 410.24 trillion SHIB in May 2021. The main dead address holding that burn has about 410.44 trillion SHIB, and burns since 2021 add up to only a small fraction of the total.

How much SHIB was burned today?
Shibburn showed about 2.47 million SHIB burned in the 24 hours to October 23, 2026, worth about $12, along with about 67.2 million SHIB in seven days and 673.4 million in 30 days. The 24-hour figure is a rolling window that changes through the day, so always check the time of any reading before comparing it with another source.

What is the most reliable SHIB burn tracker?
Shibburn is the most widely cited tracker for daily totals, but it is independent and does not publish its full method. For accuracy, check any important burn on Etherscan, which shows each transaction and the balance of every burn address. For Shibarium and ShibTorch burns, ShibWatch and the official shib.io site show whether the mechanism is actually working.

What is the Shiba Inu burn address?
The main SHIB burn address is 0xdEAD000000000000000042069420694206942069, which holds about 410.44 trillion SHIB, including Vitalik Buterin’s 2021 burn. The common dead address 0x000000000000000000000000000000000000dEaD holds about 49.46 billion SHIB. Sending SHIB to the null address destroys it, which has removed about 17.67 billion SHIB from the on-chain total supply. Always confirm the SHIB contract address before sending or checking any burn.

Why is ShibTorch not burning SHIB?
ShibTorch is under maintenance because the SHIB route on the Shibarium bridge has been closed since a September 2025 exploit that drained about $2.4 million. The portal swaps BONE fees for SHIB and bridges it to a dead address on Ethereum, so without the bridge it cannot complete burns. About 371 BONE was waiting in ShibTorch on October 22, 2026.

Why do SHIB burn trackers show different numbers?
Trackers count different addresses and exclude different wallets from supply. Shibburn reports about 340 billion more burned SHIB than the three main burn addresses hold, and it puts circulating supply near 585.49 trillion, against about 589.24 trillion on CoinMarketCap. Neither publishes a full list of the wallets it counts, so small differences between sites are normal.

Can token burns push SHIB to 1 cent?
Not at the current pace. About 673 million SHIB was burned in the past 30 days, roughly 0.0001% of the circulating supply, so burning even 1% would take about 714 years. One cent would require removing almost all of the remaining 589 trillion SHIB, or a market value of about $5.9 trillion, more than twice the entire crypto market.

IonQ, Inc. (IONQ - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.

Over the past month, shares of this company have returned -30.7%, compared to the Zacks S&P 500 composite's -1.2% change. During this period, the Zacks Computer - Integrated Systems industry, which IonQ falls in, has lost 18.5%. The key question now is: What could be the stock's future direction?

Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.

Revisions to Earnings EstimatesRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.

Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.

For the current quarter, IonQ is expected to post a loss of $0.30 per share, indicating a change of +91.6% from the year-ago quarter. The Zacks Consensus Estimate has changed -38.6% over the last 30 days.

The consensus earnings estimate of -$1.26 for the current fiscal year indicates a year-over-year change of +30.8%. This estimate has changed -40.3% over the last 30 days.

For the next fiscal year, the consensus earnings estimate of $1.17 indicates a change of +7% from what IonQ is expected to report a year ago. Over the past month, the estimate has changed +19.4%.

Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, IonQ is rated Zacks Rank #4 (Sell).

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Revenue Growth ForecastEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.

In the case of IonQ, the consensus sales estimate of $145.29 million for the current quarter points to a year-over-year change of +264.4%. The $455.01 million and $810.73 million estimates for the current and next fiscal years indicate changes of +250% and +78.2%, respectively.

Last Reported Results and Surprise HistoryIonQ reported revenues of $80.05 million in the last reported quarter, representing a year-over-year change of +286.9%. EPS of -$0.33 for the same period compares with -$0.7 a year ago.

Compared to the Zacks Consensus Estimate of $66.36 million, the reported revenues represent a surprise of +20.63%. The EPS surprise was -13.79%.

Over the last four quarters, the company surpassed EPS estimates just once. The company topped consensus revenue estimates each time over this period.

ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.

Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.

The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

IonQ is graded F on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about IonQ. However, its Zacks Rank #4 does suggest that it may underperform the broader market in the near term.

Wall Street analysts forecast that KLA (KLAC - Free Report) will report quarterly earnings of $1.18 per share in its upcoming release, pointing to a year-over-year increase of 34.1%. It is anticipated that revenues will amount to $4.05 billion, exhibiting an increase of 26.1% compared to the year-ago quarter.

The consensus EPS estimate for the quarter has undergone an upward revision of 0.3% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.

Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.

While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.

In light of this perspective, let's dive into the average estimates of certain KLA metrics that are commonly tracked and forecasted by Wall Street analysts.

The average prediction of analysts places 'Revenues- Specialty Semiconductor Process' at $173.38 million. The estimate indicates a change of +44.8% from the prior-year quarter.

Analysts expect 'Revenues- Service' to come in at $853.57 million. The estimate suggests a change of +14.6% year over year.

It is projected by analysts that the 'Revenues- Product' will reach $3.16 billion. The estimate indicates a change of +28.2% from the prior-year quarter.

Analysts predict that the 'Revenues- Semiconductor Process Control' will reach $3.63 billion. The estimate indicates a year-over-year change of +25.4%.

The combined assessment of analysts suggests that 'Revenues- PCB and Component Inspection' will likely reach $207.11 million. The estimate indicates a year-over-year change of +9.3%.

The consensus estimate for 'Geographic Revenues- China' stands at $1.00 billion. The estimate points to a change of -20.7% from the year-ago quarter.

The consensus among analysts is that 'Geographic Revenues- Rest of Asia' will reach $140.74 million. The estimate indicates a year-over-year change of +33.4%.

Analysts forecast 'Geographic Revenues- North America' to reach $522.77 million. The estimate indicates a year-over-year change of +75.5%.

The collective assessment of analysts points to an estimated 'Geographic Revenues- Europe & Israel' of $180.94 million. The estimate indicates a year-over-year change of +19.8%.

Analysts' assessment points toward 'Geographic Revenues- Taiwan' reaching $1.15 billion. The estimate indicates a change of +44.3% from the prior-year quarter.

According to the collective judgment of analysts, 'Geographic Revenues- Korea' should come in at $683.67 million. The estimate indicates a year-over-year change of +128.4%.

Based on the collective assessment of analysts, 'Geographic Revenues- Japan' should arrive at $341.37 million. The estimate suggests a change of +15.6% year over year.

View all Key Company Metrics for KLA here>>>

Over the past month, shares of KLA have returned -21% versus the Zacks S&P 500 composite's -1.2% change. Currently, KLAC carries a Zacks Rank #2 (Buy), suggesting that it may outperform. the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Analysts on Wall Street project that O'Reilly Automotive (ORLY - Free Report) will announce quarterly earnings of $0.93 per share in its forthcoming report, representing an increase of 9.4% year over year. Revenues are projected to reach $5 billion, increasing 6.2% from the same quarter last year.

The current level reflects an upward revision of 0.7% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.

Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.

While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.

Bearing this in mind, let's now explore the average estimates of specific O'Reilly Automotive metrics that are commonly monitored and projected by Wall Street analysts.

Analysts predict that the 'Sales to Do-It-Yourself Customers' will reach $2.41 billion. The estimate indicates a year-over-year change of +4.8%.

Analysts expect 'Other sales and sales adjustments' to come in at $96.83 million. The estimate indicates a change of +4% from the prior-year quarter.

It is projected by analysts that the 'Sales to professional service provider customers' will reach $2.49 billion. The estimate indicates a change of +8.1% from the prior-year quarter.

According to the collective judgment of analysts, 'Comparable store sales - YoY change' should come in at 4.4%. The estimate is in contrast to the year-ago figure of 5.6%.

Analysts' assessment points toward 'Square footage - Total' reaching 53 millions of square feet. The estimate compares to the year-ago value of 51 millions of square feet.

Based on the collective assessment of analysts, 'Number of stores opened' should arrive at 59 . Compared to the present estimate, the company reported 55 in the same quarter last year.

The collective assessment of analysts points to an estimated 'Total Stores at Beginning of the period' of 6,716 . The estimate is in contrast to the year-ago figure of 6,483 .

The consensus estimate for 'Number of stores - Total' stands at 6,754 . The estimate compares to the year-ago value of 6,538 .

The combined assessment of analysts suggests that 'Ending domestic store count' will likely reach 6,592 . The estimate is in contrast to the year-ago figure of 6,406 .

The average prediction of analysts places 'Mexico Stores at End of the Period' at 132 . Compared to the present estimate, the company reported 107 in the same quarter last year.

The consensus among analysts is that 'Sales per weighted-average square foot' will reach $93.68 million. Compared to the current estimate, the company reported $90.80 million in the same quarter of the previous year.

Analysts forecast 'Total employment' to reach 93,732 . Compared to the present estimate, the company reported 93,269 in the same quarter last year.

View all Key Company Metrics for O'Reilly Automotive here>>>

Shares of O'Reilly Automotive have demonstrated returns of +6.7% over the past month compared to the Zacks S&P 500 composite's -1.2% change. With a Zacks Rank #3 (Hold), ORLY is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Key Takeaways Baker Hughes' Q3 revenues are estimated at $7.78 billion, reflecting 11% growth from the prior-year quarter. BKR's Q3 earnings estimate rose over the past month to 64 cents per share but implies a 5.9% y/y decline. Higher oil prices may boost BKR's demand, while Middle East tensions could hurt profits via delays & costs. Baker Hughes (BKR - Free Report) is set to report third-quarter 2026 results on Oct 27, after market close.

In the last reported quarter, its earnings of 64 cents per share beat the Zacks Consensus Estimate of 51 cents, driven by strong Oilfield Services & Equipment execution, firm Industrial & Energy Technology profitability and record order momentum. The oilfield services player’s earnings topped the Zacks Consensus Estimate in each of the trailing four quarters, delivering an average surprise of 17.4%. This is depicted in the graph below:

Estimate Trend for BKRThe Zacks Consensus Estimate for third-quarter earnings per share of 64 cents has been revised upward over the past 30 days. The estimated figure indicates a 5.9% decline from the prior-year reported number.

The Zacks Consensus Estimate for revenues of $7.78 billion implies an 11% improvement from the year-ago recorded figure.

Factors to Consider for BKRAccording to data from the U.S. Energy Information Administration, average Cushing, OK, WTI spot prices stood at $80.46, $83.90 and $97.31 per barrel in July, August and September 2026, respectively, significantly higher than $68.39, $64.86 and $63.96 per barrel in the corresponding months of 2025.

The substantial year-over-year increase in crude prices, primarily driven by geopolitical tensions surrounding the Iran war, likely created a favorable business environment for Baker Hughes. Stronger commodity prices may have supported upstream spending and demand for oilfield services, potentially benefiting the company's third-quarter earnings and cash flows.

However, the positive impact of elevated oil prices may have been partly offset by disruptions stemming from the Middle East conflict. Project delays, supply-chain challenges and higher operating costs could have affected BKR's operations and weighed on quarterly profitability.

Earnings WhispersOur proven model does not conclusively predict an earnings beat for BKR this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. That is the case here, as you will see below.

Earnings ESP: BKR has an Earnings ESP of 0.00%. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.

Zacks Rank: BKR currently sports a Zacks Rank #1.

Stocks to ConsiderHere are some energy stocks that you may want to consider, as these have the right combination of elements to post an earnings beat this reporting cycle.

ExxonMobil Holdings Corporation (XOM - Free Report) has an Earnings ESP of +5.37% and currently sports a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.

XOM is scheduled to release third-quarter 2026 earnings on Oct. 30. The Zacks Consensus Estimate for XOM’s earnings is pegged at $3.96 per share, indicating a 110.6% improvement from the prior-year reported figure.

EOG Resources (EOG - Free Report) has an Earnings ESP of +2.43% and carries a Zacks Rank #2 at present. EOG is scheduled to release third-quarter 2026 earnings on Nov. 5.

The Zacks Consensus Estimate for EOG’s earnings is pegged at $4.44 per share, suggesting a 63.4% improvement from the prior-year reported figure.

BP plc (BP - Free Report) has an Earnings ESP of +7.13% and a Zacks Rank #1. BP is scheduled to release third-quarter 2026 earnings on Oct. 30.

The Zacks Consensus Estimate for BP’s earnings is pegged at $2.66 per share, suggesting a 212.9% increase from the prior-year reported figure.

CRISPR Therapeutics AG (CRSP - Free Report) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Over the past month, shares of this company have returned -10.3%, compared to the Zacks S&P 500 composite's -1.2% change. During this period, the Zacks Medical - Biomedical and Genetics industry, which CRISPR Therapeutics falls in, has lost 2.4%. The key question now is: What could be the stock's future direction?

While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.

Earnings Estimate RevisionsRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.

We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

For the current quarter, CRISPR Therapeutics is expected to post a loss of $1.07 per share, indicating a change of +8.6% from the year-ago quarter. The Zacks Consensus Estimate has changed +8.6% over the last 30 days.

The consensus earnings estimate of -$4.48 for the current fiscal year indicates a year-over-year change of +30.8%. This estimate has changed +2.1% over the last 30 days.

For the next fiscal year, the consensus earnings estimate of $3.64 indicates a change of +18.7% from what CRISPR Therapeutics is expected to report a year ago. Over the past month, the estimate has changed -5.5%.

Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, CRISPR Therapeutics is rated Zacks Rank #4 (Sell).

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Projected Revenue GrowthEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.

In the case of CRISPR Therapeutics, the consensus sales estimate of $9.95 million for the current quarter points to a year-over-year change of +1017.4%. The $32.45 million and $141.72 million estimates for the current and next fiscal years indicate changes of +824.5% and +336.7%, respectively.

Last Reported Results and Surprise HistoryCRISPR Therapeutics reported revenues of $10.18 million in the last reported quarter, representing a year-over-year change of +1043.8%. EPS of -$0.94 for the same period compares with -$1.29 a year ago.

Compared to the Zacks Consensus Estimate of $7.42 million, the reported revenues represent a surprise of +37.28%. The EPS surprise was +14.55%.

Over the last four quarters, CRISPR Therapeutics surpassed consensus EPS estimates two times. The company topped consensus revenue estimates just once over this period.

ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.

While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.

The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

CRISPR Therapeutics is graded F on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about CRISPR Therapeutics. However, its Zacks Rank #4 does suggest that it may underperform the broader market in the near term.

Key Takeaways CCEP's Southeast Asia revenues climbed 9% in first-half 2026, outpacing company-wide growth of 6.1%.Philippines' EBIT margin nears 10%, while Indonesia's sparkling volumes return to growth.CCEP's new Philippines facility is set to begin production in 2027, supporting regional capacity and demand. Coca-Cola Europacific Partners plc (CCEP - Free Report) is getting a larger share of its growth from Southeast Asia, giving the company an additional expansion lever outside its mature European markets. First-half 2026 results showed faster regional revenue growth, better execution in the Philippines and Indonesia, and continued investment in production capacity.

The opportunity is meaningful, but the region still has to prove it can scale enough to offset slower growth and tougher comparisons elsewhere. CCEP’s execution, route-to-market improvements and planned capacity additions will be central to that test.

Image Source: Zacks Investment Research

CCEP’s Southeast Asia Revenue Gains SpeedSoutheast Asia delivered solid mid-single-digit volume growth in the first half of 2026, while revenues increased 9% on an FX-neutral basis. That pace exceeded the company’s overall comparable FX-neutral revenue growth of 6.1% and highlights the region’s growing importance within CCEP’s geographic mix.

Management has described Southeast Asia as the company’s fastest-growing market area. The combination of population growth, category development and improving commercial execution gives CCEP room to expand beyond its established European base, where affordability pressure and tougher comparisons can limit growth.

CCEP Builds Momentum in the PhilippinesThe Philippines remains an important part of the Southeast Asia story. Coca-Cola Zero Sugar posted double-digit growth in the first half, while Wilkins water benefited from additional listings. Those gains show CCEP broadening demand across both sparkling and hydration categories.

Profitability is also improving. The Philippines’ EBIT margin is approaching CCEP’s 10% target, indicating that the business is making progress not only on revenues but also on operating economics. Better margins would make the market a more meaningful contributor to group profit as volumes scale.

CCEP’s Indonesia Reset Supports RecoveryIndonesia is showing signs of recovery after a weaker 2025 comparison. CCEP said sparkling volumes returned to growth in the first half, supported by products such as Coke Zero Vanilla and Sprite Nipis Mint, while Powerade was also introduced into the market.

A revamped route-to-market model is helping CCEP strengthen execution and improve category participation with distribution partners. That matters because the growth case in Indonesia depends on more than product launches. Wider availability, better outlet execution and stronger distribution can determine whether innovation translates into sustained volume gains.

How CCEP Compares With Bottling PeersThe Southeast Asia push also matters when CCEP is viewed against other Coca-Cola system bottlers. Coca-Cola HBC AG (CCHGY - Free Report) reported 9.6% organic revenue growth and 7.5% volume growth in the first half of 2026, with its Emerging segment posting 12% organic revenue growth. That performance shows how faster-growing geographies can lift the growth profile of a diversified bottler.

Coca-Cola FEMSA, S.A.B. de C.V. (KOF - Free Report) , the world’s largest Coca-Cola franchise bottler by sales volume, reported 1.2% volume growth and 6% comparable revenue growth in the first quarter of 2026. Its scale across Latin America illustrates the value of building dense distribution and broad category participation in developing beverage markets. For CCEP, the Philippines and Indonesia offer a similar strategic opportunity, though the businesses are at different stages and operate in different regions.

CCEP Adds Capacity for Future Regional DemandCCEP is also investing ahead of expected demand. Construction of a new Philippines facility remains on track for production to begin in 2027, adding capacity to support long-term growth. The project sits alongside broader investment in coolers, technology and supply-chain capabilities.

Additional capacity should give CCEP more flexibility as consumption rises and the company expands its portfolio across zero sugar, water, sports and other faster-growing categories. If distribution and profitability continue improving, Southeast Asia could become a progressively larger part of CCEP’s growth algorithm rather than remain a smaller regional contributor.

CCEP’s Ratings Keep Execution Risk in FocusSoutheast Asia strengthens CCEP’s longer-term growth case, but the stock’s current ratings still call for caution. The business faces consumer affordability pressure, rising input and logistics costs and uneven performance across developed markets, while its valuation remains elevated relative to its own history.

CCEP currently carries a Zacks Rank #4 (Sell). The stock has a Growth Score of B, but a Value Score of D, Momentum Score of C and VGM Score of C. The mix supports the view that Southeast Asia is a credible growth catalyst, but investors still need evidence that regional gains can become large enough and profitable enough to outweigh valuation, cost and mature-market risks.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

 | Source: ZENTALIS PHARMACEUTICALS

Median overall survival of 15.9 months in Cyclin E1-positive PROC, with 1–5 prior lines of therapy; safety profile in DENALI Part 1b was consistent with prior reportingMedian relative dose intensity was 84.6%, confirming high overall exposure to azenosertibDENALI Part 1b interim analysis adds to the body of evidence supporting Cyclin E1 protein expression as a predictive biomarker for azenosertib in platinum-resistant ovarian cancer
SAN DIEGO, Oct. 23, 2026 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment approach for ovarian cancer, today presented results from an interim analysis of the DENALI Part 1b study (GOG-3066) as of a May 22, 2026 data cutoff, including the first overall survival analysis for azenosertib, at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain.

"These data continue to build the body of evidence supporting azenosertib as a potential treatment in Cyclin E1-positive platinum-resistant ovarian cancer, underpinning our development approach through the ongoing registration-intended DENALI Part 2 and ASPENOVA Phase 3 confirmatory trials. For patients with Cyclin E1-positive PROC who have limited effective treatment options, we are working to deliver something that has not existed — a targeted, oral treatment that offers more convenience and choice," said Julie Eastland, Chief Executive Officer of Zentalis Pharmaceuticals.

"The overall survival results from DENALI Part 1b are particularly meaningful given the poor prognosis associated with Cyclin E1-positive tumors and the heavily pretreated nature of this trial patient population," said Fiona Simpkins, M.D., Professor at the University of Pennsylvania Perelman School of Medicine and Lead Investigator for the DENALI study and The GOG Foundation, Inc. (GOG-F). "The separation in median overall survival between Cyclin E1-positive and Cyclin E1-negative patients — 15.9 months versus 7.5 months — strongly supports Cyclin E1 protein expression as a clinically relevant and predictive patient selection biomarker for azenosertib. Taken together with the response data and manageable adverse events, these findings provide important evidence supporting continued development of azenosertib in this biomarker-selected population with high unmet need."

Updated DENALI Part 1b Efficacy Results
As of the May 22, 2026 data cutoff, DENALI Part 1b enrolled 102 patients with PROC regardless of Cyclin E1 protein expression who had received between one and five prior lines of therapy, with prior bevacizumab required. This was a heavily pretreated population: 97% had received a taxane, 91% bevacizumab, 55% a PARP inhibitor, and 15% mirvetuximab soravtansine, with a median of three prior lines of therapy. Cyclin E1 status was retrospectively determined by immunohistochemistry using a proprietary cutoff, with 94 patients evaluable (Cyclin E1 IHC-positive: n=48, 51%; Cyclin E1 IHC-negative: n=46).

Overall Survival (OS):

Cyclin E1 IHC-positive (n=48): median OS of 15.9 months (95% CI, 8.7–21.2); 31 events had occurred (65%)Cyclin E1 IHC-negative (n=46): median OS of 7.5 months (95% CI, 5.8–12.3); 34 events had occurred (74%) Objective Response Rate (ORR) and Duration of Response (DOR):

ORR in response-evaluable Cyclin E1 IHC-positive patients (n=43): 37.2% (95% CI, 23.0–53.3)ORR in all Cyclin E1 IHC-positive patients (n=48): 33.3% (95% CI, 20.4–48.4)Median DOR: 5.5 months (95% CI, 4.5–15.9)
The updated ORR includes a patient with a confirmed response after the prior cutoff. The current median DOR of 5.5 months reflects a more mature dataset with less censoring than the prior cutoff, including two patients with particularly durable responses exceeding 15 and 20 months.

Safety
The safety profile was consistent with prior reporting. The most common treatment-related adverse events (TRAEs) were nausea, fatigue, diarrhea, thrombocytopenia, decreased appetite, anemia, and neutropenia. The most common non-hematologic Grade ≥3 TRAE was fatigue (16%). Grade ≥3 hematologic TRAEs included thrombocytopenia (12%), anemia (11%), and neutropenia (11%).

The median relative dose intensity was 84.6%, confirming that overall exposure to azenosertib remained high despite dose modifications. TRAEs led to dose interruption in 56.9% of patients, dose reduction in 43.1%, and discontinuation in 19.6%. Serious TRAEs occurred in 21.6% of patients.

The ESMO slides inclusive of the full interim analysis dataset presented at the medical meeting are available on the Zentalis website under scientific publications at the following link: https://zentalis.com/science/scientific-publications/

About the DENALI Clinical Trial
DENALI is a multi-part Phase 2 registration-intended clinical trial (NCT05128825, GOG-3066) studying azenosertib in patients with PROC, conducted in collaboration with The GOG Foundation, Inc. (GOG-F).

Part 1b enrolled 102 patients with PROC regardless of Cyclin E1 protein expression, all treated at 400 mg QD 5:2 (five days of once-daily administration of azenosertib, followed by two days without azenosertib). The primary endpoint was objective response rate per RECIST v1.1; secondary endpoints included duration of response, progression-free survival, overall survival, and safety.

Part 2 is prospectively enrolling PROC patients with Cyclin E1 protein overexpression based on Zentalis' proprietary immunohistochemistry cutoff. Part 2, in total, is designed to support accelerated approval, pending positive study outcomes and further discussions with the FDA. The study design consists of the following parts:

Part 2a: Dose confirmation evaluated two doses, 300 mg QD 5:2 and 400 mg QD 5:2, with approximately 30 patients enrolled per dose group. 400 mg QD 5:2 was selected as the optimal monotherapy dose. Recruitment at the 300 mg QD 5:2 dose level has been discontinued. All patients enrolled in Part 2a will contribute to the overall safety database submitted to the FDA.Part 2b: Enrollment expansion at the selected 400 mg QD 5:2 dose up to approximately 100 patients, including patients at this dose in Part 2a. Enrollment in this cohort is complete.Part 2c: Expansion of the study population, expected to enroll approximately 40 patients previously treated with a taxane-containing regimen for PROC. This cohort is currently enrolling.
For physician and patient information about the DENALI trial, please visit www.denalitrial.com.

About ASPENOVA Clinical Trial
ASPENOVA is a Phase 3 randomized, confirmatory clinical trial designed to support full approval of azenosertib in patients with Cyclin E1-positive PROC. The trial is expected to enroll approximately 420 patients and compare azenosertib monotherapy at 400mg QD 5:2 to investigator's choice of standard-of-care single-agent chemotherapy (paclitaxel, pegylated liposomal doxorubicin [PLD], gemcitabine, or topotecan) in this biomarker-selected population. The primary endpoint is progression-free survival (PFS); key secondary endpoints include overall survival (OS) and overall response rate (ORR). The trial design was based on feedback from the U.S. FDA regarding requirements for seeking approval under the accelerated approval pathway and requirements to support potential conversion to full approval.

About Azenosertib
Azenosertib is an investigational, potentially first-in-class, selective, and orally bioavailable inhibitor of WEE1 currently being evaluated in clinical studies in ovarian cancer and additional tumor types. WEE1 acts as a master regulator of the G1-S and G2-M cell cycle checkpoints, through negative regulation of both CDK1 and CDK2, to prevent replication of cells with damaged DNA. By inhibiting WEE1, azenosertib enables cell cycle progression, despite high levels of DNA damage, thereby resulting in the accumulation of DNA damage and leading to mitotic catastrophe and cancer cell death.

Azenosertib is in late-stage development as a potential treatment for Cyclin E1-positive platinum-resistant ovarian cancer (PROC). There is currently no approved treatment option specifically for this biomarker-selected population which comprises approximately 50% of PROC patients. Cyclin E1 protein overexpression has been established as a sensitive and specific predictive biomarker for identifying patients who could potentially derive benefit from azenosertib treatment.

About Zentalis Pharmaceuticals
Zentalis is a clinical oncology innovator developing a treatment approach for ovarian cancer and multiple tumor types. Leveraging therapeutics development and biomarker expertise, Zentalis is advancing monotherapy and combination studies of its investigational first-in-class WEE1 inhibitor, azenosertib. Focused on translating WEE1 science into clinical practice, we aim to equip physicians with a targeted, non-chemo, orally available medicine that enhances treatment experience, choice, and outcomes. Our mission: to unburden cancer patients with more convenience and care.​

For more information, please visit www.zentalis.com. Follow Zentalis on LinkedIn at www.linkedin.com/company/zentalis-pharmaceuticals

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, as amended. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, but not limited to, statements regarding the continued development of azenosertib; the clinical and therapeutic potential of azenosertib; the potential for azenosertib to be first-in-class; the broad franchise potential of azenosertib; the Company’s biomarker-driven strategy for azenosertib, including the ability of Cyclin E1 to be a highly selective and predictive biomarker for response to azenosertib; and our participation in conference presentations. The terms “anticipate,” “advance,” “believe,” “design,” “develop,” “expect,” “intent,” “look forward,” “on track,” “plan,” “position,” “potential,” “runway,” “strategy,” “support,” “target,” “upcoming,” and “will” and similar references are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the following: our limited operating history, which may make it difficult to evaluate our current business and predict our future success and viability; we have and expect to continue to incur significant losses; our need for additional funding, which may not be available; our substantial dependence on the success of azenosertib; our plans, including the costs thereof, of development of companion diagnostics; the outcome of preclinical testing and early trials may not be predictive of the success of later clinical trials; potential unforeseen events during clinical trials could cause delays or other adverse consequences; risks relating to the regulatory approval process or ongoing regulatory obligations; our product candidates may cause serious adverse side effects; inability to maintain our collaborations, or the failure of these collaborations; our reliance on third parties; effects of significant competition; the possibility of system failures or security breaches; risks relating to intellectual property; our ability to attract, retain and motivate qualified personnel, and risks relating to management transitions; significant costs as a result of operating as a public company; and the other important factors discussed under the caption “Risk Factors” in our most recently filed periodic report on Form 10-K or 10-Q and subsequent filings with the U.S. Securities and Exchange Commission (SEC) and our other filings with the SEC. Any such forward-looking statements represent management’s estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.

ZENTALIS® and its associated logo are trademarks of Zentalis and/or its affiliates. All website addresses and other links in this press release are for information only and are not intended to be an active link or to incorporate any website or other information into this press release. 

Contact: 
Aron Feingold
VP, Investor Relations & Corporate Communications
[email protected]

, /PRNewswire/ -- Simpson Manufacturing Co., Inc. (the "Company") (NYSE: SSD), an industry leader in engineered structural connectors and building solutions, today announced that on October 22, 2026, the Company's Board of Directors (the "Board") declared a regular quarterly dividend of 30 cents per share on the Company's common stock. The dividend is payable on January 28, 2027, to stockholders of record on January 7, 2027.

About Simpson Manufacturing Co., Inc. 
Simpson Manufacturing Co., Inc., headquartered in Pleasanton, California, through its subsidiaries, including Simpson Strong-Tie Company Inc., designs, engineers and is a leading manufacturer of wood construction products, including connectors, truss plates, fastening systems, fasteners and shear walls, and concrete construction products, including adhesives, specialty chemicals, mechanical anchors, powder actuated tools and reinforcing fiber materials. The Company primarily supplies its building product solutions to both the residential and commercial markets in North America and Europe. The Company's common stock trades on the New York Stock Exchange under the symbol "SSD."

CONTACT:                                                               
Addo Investor Relations
[email protected] 
(310) 829-5400

SOURCE Simpson Manufacturing Co., Inc.

Wall Street analysts expect Oneok Inc. (OKE - Free Report) to post quarterly earnings of $1.46 per share in its upcoming report, which indicates a year-over-year decline of 2%. Revenues are expected to be $11.77 billion, up 36.3% from the year-ago quarter.

Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 2.3% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.

Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.

While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.

That said, let's delve into the average estimates of some Oneok metrics that Wall Street analysts commonly model and monitor.

Analysts expect 'Raw feed throughput - Natural Gas Liquids' to come in at 1,622.48 thousands of barrels of oil per day. The estimate is in contrast to the year-ago figure of 1,574.00 thousands of barrels of oil per day.

The average prediction of analysts places 'Adjusted EBITDA- Natural Gas Liquids' at $739.00 million. The estimate compares to the year-ago value of $748.00 million.

The consensus among analysts is that 'Adjusted EBITDA- Refined Products & Crude' will reach $596.29 million. The estimate compares to the year-ago value of $582.00 million.

According to the collective judgment of analysts, 'Adjusted EBITDA- Natural Gas Pipelines' should come in at $227.08 million. The estimate compares to the year-ago value of $200.00 million.

Analysts' assessment points toward 'Adjusted EBITDA- Natural Gas Gathering and Processing' reaching $568.12 million. Compared to the present estimate, the company reported $566.00 million in the same quarter last year.

View all Key Company Metrics for Oneok here>>>

Oneok shares have witnessed a change of +3% in the past month, in contrast to the Zacks S&P 500 composite's -1.2% move. With a Zacks Rank #3 (Hold), OKE is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

, /PRNewswire/ -- Berger Montague, a leading national plaintiffs' law firm, announces a class action lawsuit against Skechers U.S.A., Inc. (formerlyNYSE: SKX) ("Skechers" or the "Company") on behalf of investors who sold Skechers securities, or who received the $63 per share merger consideration, during the period from April 24, 2025 through September 12, 2025 (the "Class Period"). The deadline to apply for lead plaintiff is December 21, 2026.

Q&A

What is this lawsuit about?
The complaint alleges that Skechers' senior executives, including founder and CEO Robert Greenberg and President Michael Greenberg, teamed up with 3G Capital and financial advisor Greenhill & Co. to buy out the Company's unaffiliated shareholders at an artificially depressed price of $63 per share in a $9.4 billion take-private transaction. Management allegedly believed tariffs would have a minimal, and possibly even positive, effect on Skechers' business, yet on April 24, 2025, the Company withdrew its 2025 guidance, citing changes in global trade policies. Between April 23 and April 27, 2025, management also allegedly cut the Company's financial projections three times, so that the $63 price would appear fair. According to the complaint, the Information Statement left out those facts, as well as the Greenbergs' December 2024 decision to engage with 3G on an exclusive basis. The Greenbergs also elected the mixed consideration of $57 per share in cash plus one equity unit, a nominal total of $86 per share, which allegedly gave them over $1 billion in cash proceeds while they rolled over more than 18 million shares into the private entity. Shareholders who sold during the Class Period, or who received the $63 merger consideration, allegedly did so at artificially deflated prices.

Who is Skechers?
Skechers, headquartered in Manhattan Beach, California, designs, develops, and markets lifestyle and performance footwear, apparel, and accessories. Skechers' Class A common stock formerly traded on the New York Stock Exchange under the ticker symbol SKX until the Company was taken private in September 2025.

What do I need to do?

Investor Deadline: Investors who sold Skechers securities, or who received the $63 per share merger consideration, during the Class Period may, no later than December 21, 2026, seek to be appointed as a lead plaintiff representative of the class.

If you are a Skechers investor and would like to learn more about this action, or to discuss your rights, please contact Berger Montague: Andrew Abramowitz at [email protected] or (215) 875-3015 or Caitlin Adorni at [email protected] or (267) 764-4865 or visit our website.

About Berger Montague

Berger Montague is one of the nation's preeminent law firms focusing on complex civil litigation, class actions, and mass torts in federal and state courts throughout the United States. With more than $2.4 billion in 2025 post-trial judgments alone, the Firm is a leader in the fields of complex litigation, antitrust, consumer protection, defective products, environmental law, employment law, securities, and whistleblower cases, among many other practice areas. For over 55 years, Berger Montague has played leading roles in precedent-setting cases and has recovered over $50 billion for its clients and the classes they have represented. Berger Montague is headquartered in Philadelphia and has offices in Chicago; Malvern, PA; Minneapolis; San Diego; San Francisco; Toronto, Canada; Washington, D.C., and Wilmington, DE.

For more information or to discuss your rights, please contact:

Andrew Abramowitz
Berger Montague
(215) 875-3015
[email protected]

Caitlin Adorni
Berger Montague
(267) 764-4865
[email protected]

SOURCE Berger Montague

Dear JUST Community, 

As our ecosystem has grown, several early initiatives have been phased out or integrated, while our core offerings have matured. To sharpen our strategic focus, JUST has restructured its brand architecture around three flagship product lines and unified all governance and buybacks under JUST DAO. Alongside this upgrade, our redesigned official website is now live. Here are the key updates: 

I. Core Product Architecture

JUST is an open finance network for the global on-chain economy, rooted in TRON and connected to global markets. It continuously repurchases JST using real business revenue. The ecosystem mainly focuses on the following three core product lines: 

JustLend: Put TRON assets to work through lending, sTRX, and Energy services for higher efficiency.

GasFree: Pay transfer fees directly in USDT or USDD to make on-chain transactions frictionless for everyone.

USDD: Access stablecoin liquidity and yield opportunities through overcollateralized minting, PSM swap, and structured products.

Alongside these three products, several other ecosystem businesses make up the full JUST suite.

II. Governance and Buybacks Unified Under JUST DAO

JST serves as the core governance token across the JUST ecosystem, used to submit proposals and cast votes. Governance and buyback-and-burn operations are now formally unified under JUST DAO. Operations previously managed by JustLend Grants DAO have migrated entirely to JUST DAO, establishing a single governance hub across JustLend, USDD, GasFree, and other ecosystem initiatives.

JST's long-term value accrual is anchored in real protocol revenue generated across the ecosystem. Revenue from JustLend and GasFree will continue to fund JST buybacks, and net revenue from USDD exceeding $10 million will be allocated directly toward the buyback program. Historical buyback and burn records will be archived and detailed on the official analytics page, now under the JUST DAO name, to maintain full data auditing and traceability. 

Governance infrastructure has also been migrated directly to the JUST official website, providing a single interface for ecosystem-wide proposals and voting.

III. New Official Website & Whitepaper

The redesigned JUST website is now live, featuring an integrated analytics dashboard and a dedicated buyback-and-burn tracker. All historical and ongoing burn metrics are updated regularly for full on-chain transparency. 

The JUST Whitepaper has also been updated to detail the ecosystem's streamlined architecture, core product lines, and revised JST tokenomics. 

Going forward, JUST DAO will continue to build long-term value for JST through a clearer business structure and more transparent data disclosure. We invite you to explore the new official website and the upgraded JUST ecosystem. 

Thank you for your continued support!

JUST DAO Team

October 23, 2026 (SGT)